Reduced tumor lymphocytic infiltration in the residual disease (RD) of post-neoadjuvant chemotherapy (NAC) triple-negative breast cancers (TNBC) is associated with Ras/MAPK activation and poorer survival
Version 2 2024-06-04, 06:41Version 2 2024-06-04, 06:41
Version 1 2016-07-13, 13:57Version 1 2016-07-13, 13:57
conference contribution
posted on 2024-06-04, 06:41authored byJM Balko, C Denkert, R Salgado, Martin O'HelyMartin O'Hely, P Savas, PA Beavis, PK Darcy, S Combs, DL Rimm, JM Giltnane, MV Estrada, ME Sanders, RS Cook, K Wang, VA Miller, PJ Stephens, R Yelensky, JA Pinto, F Doimi, H Gomez, CL Arteaga, S Loi
Reduced tumor lymphocytic infiltration in the residual disease (RD) of post-neoadjuvant chemotherapy (NAC) triple-negative breast cancers (TNBC) is associated with Ras/MAPK activation and poorer survival